Olympus - 19-gauge Needle

Completed

Conditions studied: Lung Cancer

In brief

The purpose of this study is to test whether the 19-gauge needle can collect more tissue and get better sampling during a bronchoscopy procedure.

Key facts

Study ID

NCT03270670

Run by

Duke University

People needed

50

Starts

2017-08-21

Expected to finish

2019-01-30

Last updated by the study team

2019-09-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects with known or suspected lung cancer with mediastinal adenopathy as defined by a mediastinal lymph node >0.5 cm in short axis on EBUS or any lymph node with uptake on FDG-PET scan that is higher than background PET activity.
• Participants must lack bleeding disorders

You may not qualify if…

• Subjects who lack fitness for flexible bronchoscopy as determined by the physician performing the bronchoscopy before the procedure
• Subjects with suspected sarcoidosis, lymphoma, or metastatic cancer from other sites (i.e. those without a known or suspected lung primary)
• Subjects on anticoagulation (other than Aspirin) whom cannot have their anticoagulation held for the procedure due to other clinical reasons (i.e. recent cardiac stent placement).

Where it is running

• Washington University in St. Louis — St Louis, Missouri, United States
• Duke Medical Center — Durham, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.